5min chapter

The Curbsiders Internal Medicine Podcast cover image

#342 Checkpoint Inhibitors: The power, and adverse effects, of immunotherapy (ACP 2022)

The Curbsiders Internal Medicine Podcast

CHAPTER

What's the Difference Between Infusion Reactions and Non-Hodgkin Lumthoma?

You'll see it less commonly, but very importantly, in hodgkin lumthoma. But i would say that the practising inturnist is going to see this in lung cancer. And then let's not forget melanoma. Melanoma and renal cell have long been understood as emunologically active tumors. The good thing we want to inflame is the cancer. I mean, ta an lead to long term disease control, even cure. What does it actually look like for patients? A wat, what kind of experience do they have receiving these treatments? So molly, it's very different than traditional cemo theraby a, and it's even different then than

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode